Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Still a scrap.
View:
Post by Alex1726 on May 15, 2024 4:07pm

Still a scrap.

Even the ones that failes(Annovis) has a greater market value. They just don't want to conduct real clinical trials. 

Sell that scrap and buy anavex if you want to make money in AD.

TAKE A LOOK AT AVXL you'll know why those fuc... crooks at PMN don't deserve any attention.
Comment by Alex1726 on May 15, 2024 4:24pm
The study's outcome represents a noteworthy milestone, with blarcamesine being among the first drugs to exhibit efficacy on biomarkers of neurodegeneration. Moreover, blarcamesine demonstrated a strong anti-amyloid effect, as indicated by a significant increase in the plasma Aβ42/40 ratio, a validated biomarker of amyloid beta pathology. MRI scans revealed a notable reduction in brain volume ...more  
Comment by Alex1726 on May 15, 2024 4:31pm
Don't waste your time with that lazy guys , what do you THINK Gene Williams will do during summer time : Working hard for shareholders? NO WAY. Oh by the way blarcamesine is a one daily pill.
Comment by Alex1726 on May 15, 2024 5:00pm
https://www.defenseworld.net/2024/05/12/anavex-life-sciences-nasdaqavxl-receives-buy-rating-from-hc-wainwright.html Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a report released on Friday, Benzinga reports. They currently have a $40.00 target price on the biotechnology company’s stock.
Comment by Speyeder999 on May 15, 2024 5:07pm
Thanks for the plug......and you're saying people should ignore the Class Action Lawsuit fiiled by investors 2 days ago, right?
Comment by Alex1726 on May 15, 2024 5:12pm
That was more than 2 days ago https://ca.finance.yahoo.com/news/anavex-life-sciences-corp-nasdaq-151830892.html Take a look at the last conference call with analysts . No one talked about that. Take a look at the pipeline on their web site , it is much more than only AD and the're very advanced on many fronts
Comment by Alex1726 on May 15, 2024 5:19pm
They're on the way for approval in Europe they say they will submit for approval this year. https://ca.finance.yahoo.com/news/anavex-received-agreement-committee-medicinal-123000450.html
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities